Search

Your search keyword '"Donna M. Krasnewich"' showing total 90 results

Search Constraints

Start Over You searched for: Author "Donna M. Krasnewich" Remove constraint Author: "Donna M. Krasnewich"
90 results on '"Donna M. Krasnewich"'

Search Results

1. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

2. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

3. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

4. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

5. One is the loneliest number: genotypic matchmaking using the electronic health record

6. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

7. Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder

8. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

9. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

10. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

11. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

12. International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1‐CDG ): Diagnosis, follow‐up, and management

13. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

14. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

15. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

16. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

17. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor beta Signaling

18. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

19. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

20. The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease

21. A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay

22. Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation

23. A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3

24. The dbGaP data browser: a new tool for browsing dbGaP controlled-access genomic data

25. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up

26. IRF2BPL Is Associated with Neurological Phenotypes

27. A Comprehensive Iterative Approach is Highly Effective in Diagnosing Individuals who are Exome Negative

28. Expanding the clinical and molecular characteristics of PIGT-CDG, a disorder of glycosylphosphatidylinositol anchors

29. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases

30. International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up

31. Human glycosylation disorders

32. Congenital disorders of glycosylation and intellectual disability

33. MARRVEL: Integration of Human and Model Organism Genetic Resources to Facilitate Functional Annotation of the Human Genome

34. Correlation of Kidney Function, Volume and Imaging Findings, and PKHD1 Mutations in 73 Patients with Autosomal Recessive Polycystic Kidney Disease

35. Hereditary Inclusion Body Myopathy: A decade of progress

36. Lysosomal Storage Disorders in the Newborn

37. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype

38. Clinical features in adults with congenital disorders of glycosylation type Ia (CDG-Ia)

39. Quantitative dysmorphology assessment in Fabry disease

40. Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy

41. Clinical, biochemical, and molecular diagnosis of a free sialic acid storage disease patient of moderate severity

42. Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation

43. Deficiency of UDP-GlcNAc:Dolichol Phosphate N-Acetylglucosamine-1 Phosphate Transferase (DPAGT1) Causes a Novel Congenital Disorder of Glycosylation Type Ij

44. Sialic acid storage disease of the Salla phenotype in American monozygous twin female sibs

45. Biochemical and molecular analyses of infantile free sialic acid storage disease in North American children

46. Phosphomannomutase activity in congenital disorders of glycosylation type Ia determined by direct analysis of the interconversion of mannose-1-phosphate to mannose-6-phosphate by high-pH anion-exchange chromatography with pulsed amperometric detection

47. A deletion-insertion mutation in the phosphomannomutase 2 gene in an African American patient with congenital disorders of glycosylation-Ia

49. Gaucher Disease and Parkinsonism: A Phenotypic and Genotypic Characterization

50. Dominant Inheritance of Sialuria, an Inborn Error of Feedback Inhibition

Catalog

Books, media, physical & digital resources